TOKYO--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback